A new reusable insulin injector pen combined with a smartphone app that helps insulin-dependent diabetes patients calculate their doses and keeps track of injection data is now available in the United ...

Need to automatically compile data gathered by an insulin pen and send it to a healthcare provider? There’s a device-connected app for that. Less than a year after signing their initial distribution ...

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...

Medtronic has received clearance from the US Food and Drug Administration (FDA) for its new InPen app, paving the way for introducing its Smart multiple daily injection (MDI) system. The system offers ...

The InPen is for use with U-100 Lilly Humalog and Novo Nordisk Novolog rapid-acting insulin and indicated for persons aged 12 years and older. Companion Medical announced the launch of the InPen ...

Management of Type 1 and Type 2 diabetes is going high tech, thanks to a collaboration between Welldoc and Eli Lilly. The companies are partnering to integrate Welldoc's software into Lilly's ...

This morning medical device company Medtronic announced its plans to buy Companion Medical, which is best known for making the InPen, an insulin pen that integrates a companion app, for an undisclosed ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted clearance for a smart insulin pen to be used by children with diabetes aged at least 7 years, ...

Insulin dosage is an ongoing area of interest among digital health companies. Initiating and increasing insulin dosages represent some of the greatest challenges to help Type 2 diabetes patients ...

CALIFORNIA, USA — Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom. Beginning Jan. 1, 2026 ...

COLUMBIA, Md. and INDIANAPOLIS, Feb. 25, 2021 /PRNewswire/ -- Welldoc, Inc., and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc's ...